-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Sonnet BioTherapeutics Holdings, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2019.
- Sonnet BioTherapeutics Holdings, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $158K.
- Sonnet BioTherapeutics Holdings, Inc. annual Income Tax Expense (Benefit) for 2019 was $73.7K.
- Sonnet BioTherapeutics Holdings, Inc. annual Income Tax Expense (Benefit) for 2018 was -$701K, a 8.81% decline from 2017.
- Sonnet BioTherapeutics Holdings, Inc. annual Income Tax Expense (Benefit) for 2017 was -$644K, a 425% decline from 2016.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)